Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Pharmacogenomic Variants for Cardiology Therapeutics: the Lighthouse Pilot (Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects)

NCT04702113 is registered in ClinicalTrials.gov with Cipherome, Inc. as lead sponsor.

NCT NCT04702113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04702113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Pharmacogenomic Variants for Cardiology Therapeutics: the Lighthouse Pilot (Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects)
Lead sponsor
Cipherome, Inc.
Phase
Not applicable
Overall status
Completed
Start date
December 3, 2020
Completion date
July 27, 2023
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, ischemic stroke, myocardial infarction, stent thrombosis, thrombosis